These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8876886)

  • 21. The prognosis and treatment of true local cutaneous recurrent malignant melanoma.
    Brown CD; Zitelli JA
    Dermatol Surg; 1995 Apr; 21(4):285-90. PubMed ID: 7728476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is a Wider Margin (2 cm vs. 1 cm) for a 1.01-2.0 mm Melanoma Necessary?
    Doepker MP; Thompson ZJ; Fisher KJ; Yamamoto M; Nethers KW; Harb JN; Applebaum MA; Gonzalez RJ; Sarnaik AA; Messina JL; Sondak VK; Zager JS
    Ann Surg Oncol; 2016 Jul; 23(7):2336-42. PubMed ID: 26957503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial.
    Hayes AJ; Maynard L; Coombes G; Newton-Bishop J; Timmons M; Cook M; Theaker J; Bliss JM; Thomas JM; ; ;
    Lancet Oncol; 2016 Feb; 17(2):184-192. PubMed ID: 26790922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial.
    Utjés D; Malmstedt J; Teras J; Drzewiecki K; Gullestad HP; Ingvar C; Eriksson H; Gillgren P
    Lancet; 2019 Aug; 394(10197):471-477. PubMed ID: 31280965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of local recurrence and resection margins for stage I primary cutaneous malignant melanomas.
    Zeitels J; LaRossa D; Hamilton R; Synnestvedt M; Schultz D
    Plast Reconstr Surg; 1988 May; 81(5):688-93. PubMed ID: 3362987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1-2 mm in Thickness): Analysis of 2131 Patients Treated at a Single Center.
    Haydu LE; Stollman JT; Scolyer RA; Spillane AJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Bonenkamp JJ; Thompson JF
    Ann Surg Oncol; 2016 Apr; 23(4):1071-81. PubMed ID: 25956574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case-Control Study.
    MacKenzie Ross AD; Haydu LE; Quinn MJ; Saw RP; Shannon KF; Spillane AJ; Stretch JR; Scolyer RA; Thompson JF
    Ann Surg Oncol; 2016 Apr; 23(4):1082-9. PubMed ID: 26561405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V; Breuninger H; Garbe C; Moehrle M
    Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The management of cervical lymph nodes in patients with cutaneous melanoma.
    Martin RC; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Colman MH; Gao K; Thompson JF
    Ann Surg Oncol; 2012 Nov; 19(12):3926-32. PubMed ID: 22669449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
    Zogakis TG; Essner R; Wang HJ; Foshag LJ; Morton DL
    Ann Surg Oncol; 2007 May; 14(5):1604-11. PubMed ID: 17333418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1 or 2 cm margins of excision for T2 melanomas: do they impact recurrence or survival?
    Hudson LE; Maithel SK; Carlson GW; Rizzo M; Murray DR; Hestley AC; Delman KA
    Ann Surg Oncol; 2013 Jan; 20(1):346-51. PubMed ID: 23010731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial.
    Balch CM; Soong S; Ross MI; Urist MM; Karakousis CP; Temple WJ; Mihm MC; Barnhill RL; Jewell WR; Wanebo HJ; Harrison R
    Ann Surg Oncol; 2000 Mar; 7(2):87-97. PubMed ID: 10761786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal resection margin for cutaneous malignant melanoma.
    Elder DE; Guerry D; Heiberger RM; LaRossa D; Goldman LI; Clark WH; Thompson CJ; Matozzo I; Van Horn M
    Plast Reconstr Surg; 1983 Jan; 71(1):66-72. PubMed ID: 6849024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial.
    Gillgren P; Drzewiecki KT; Niin M; Gullestad HP; Hellborg H; Månsson-Brahme E; Ingvar C; Ringborg U
    Lancet; 2011 Nov; 378(9803):1635-42. PubMed ID: 22027547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis of thick cutaneous melanoma of the trunk and extremity.
    Coit D; Sauven P; Brennan M
    Arch Surg; 1990 Mar; 125(3):322-6. PubMed ID: 2306180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The time from diagnostic excision biopsy to wide local excision for primary cutaneous malignant melanoma may not affect patient survival.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2002 Jul; 147(1):48-54. PubMed ID: 12100184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Staged Excision With Permanent Section Margin Control for Cutaneous Head and Neck Melanoma.
    Moyer JS; Rudy S; Boonstra PS; Kraft C; Chinn SB; Baker SR; Schwartz JL; Bichakjian CK; Fullen D; Durham AB; Lowe L; Johnson TM
    JAMA Dermatol; 2017 Mar; 153(3):282-288. PubMed ID: 28002553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Narrow resection of cutaneous melanoma.
    Beasley K; Cartotto RC
    J Cutan Med Surg; 1998 Jan; 2(3):133-7. PubMed ID: 9479077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.